Business Description
Imeik Technology Development Co Ltd
No. Jia 92 Jianguo Road, 21st, Block C, Shimao Building, Chaoyang District, Beijing, CHN, 100022
Compare
Compare
Traded in other countries / regions
300896.China
Description
Imeik Technology Development Co Ltd is a national enterprise focusing on the research and development, manufacture and sales of biomedical materials. The company's products include Medical Cosmetic Platform; General Surgery Platform; and Biological Technology Platform.
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 53.5 | |||||
Equity-to-Asset | 0.96 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | 0.06 | |||||
Interest Coverage | 421.09 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 323.13 | |||||
Beneish M-Score | 0.49 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 49.9 | |||||
3-Year EBITDA Growth Rate | 75.1 | |||||
3-Year EPS without NRI Growth Rate | 79.9 | |||||
3-Year FCF Growth Rate | 92.4 | |||||
3-Year Book Growth Rate | 111.4 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 32.07 | |||||
9-Day RSI | 35.78 | |||||
14-Day RSI | 40.16 | |||||
6-1 Month Momentum % | 31.77 | |||||
12-1 Month Momentum % | 0.6 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 27.04 | |||||
Quick Ratio | 26.81 | |||||
Cash Ratio | 25.83 | |||||
Days Inventory | 118.79 | |||||
Days Sales Outstanding | 12.89 | |||||
Days Payable | 49.55 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.37 | |||||
Forward Dividend Yield % | 0.37 | |||||
5-Year Yield-on-Cost % | 0.37 | |||||
3-Year Average Share Buyback Ratio | -10.1 |
Profitability Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 94.09 | |||||
Operating Margin % | 71.31 | |||||
Net Margin % | 65.9 | |||||
ROE % | 22.32 | |||||
ROA % | 21.45 | |||||
ROIC % | 94.08 | |||||
ROC (Joel Greenblatt) % | 633.65 | |||||
ROCE % | 25.95 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 110.99 | |||||
PE Ratio without NRI | 110.99 | |||||
Price-to-Owner-Earnings | 211.48 | |||||
PEG Ratio | 1.42 | |||||
PS Ratio | 73.14 | |||||
PB Ratio | 22.3 | |||||
Price-to-Tangible-Book | 22.36 | |||||
Price-to-Free-Cash-Flow | 118.55 | |||||
Price-to-Operating-Cash-Flow | 115.11 | |||||
EV-to-EBIT | 91.43 | |||||
EV-to-EBITDA | 91.43 | |||||
EV-to-Revenue | 70.83 | |||||
EV-to-FCF | 119.06 | |||||
Price-to-Projected-FCF | 19.33 | |||||
Price-to-Peter-Lynch-Fair-Value | 4.94 | |||||
Price-to-Graham-Number | 10.5 | |||||
Price-to-Net-Current-Asset-Value | 31.07 | |||||
Price-to-Net-Cash | 32.61 | |||||
Earnings Yield (Greenblatt) % | 1.08 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Executives
EMBED
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 1,619.23 | ||
EPS (TTM) (¥) | 4.93 | ||
Beta | 0 | ||
Volatility % | 30.91 | ||
14-Day RSI | 40.16 | ||
14-Day ATR (¥) | 20.54996 | ||
20-Day SMA (¥) | 583.3995 | ||
12-1 Month Momentum % | 0.6 | ||
52-Week Range (¥) | 391.09 - 668.19 | ||
Shares Outstanding (Mil) | 216.36 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Imeik Technology Development Co Ltd Filings
Document | Form | Filing Date | ||
---|---|---|---|---|
No Filing Data |